MUMBAI, 24 September 2026 — Elevate Campuses Limited’s ₹2,100 crore fresh IPO had bids for 6,794,110 shares against 33,673,468 shares in the demand denominator at 5 p.m. IST on September 23. That equates to approximately 0.20 times.

Verified details

Company Elevate Campuses Limited
Application window 23-Sep-2026 to 25-Sep-2026
Price band Rs. 343 to Rs. 362 per Equity Share
Quoted lot unit 41 Equity Shares and in multiples thereof
Registrar KFin Technologies Limited
Demand data timestamp 23-Sep-2026 17:00:00 IST

Which category contributed the highest coverage?

Non-institutional demand stood around 0.30 times, qualified institutional demand about 0.18 times, and retail demand approximately 0.13 times. These are allocation-specific readings, not three independent estimates of company value. Adding or simply averaging them would misstate the total because each denominator is different.

Offer size is not the demand denominator

NSE’s ₹21,000 million fresh-issue description converts to ₹2,100 crore. Its anchor reservation is 26,104,972 shares. Reserved portions and the share quantity shown in a particular bid table should not be conflated with the overall monetary offer size. A subscription ratio measures recorded bids against the corresponding allocation, not how much of the entire offer has already been paid to the issuer.

Application figures and reporting boundary

The price band is ₹343–₹362 and the quoted lot is 41 shares. The upper-band value of one lot is ₹14,842. KFin Technologies is registrar. The issuer-detail timestamp was preferred over the older roughly 0.08-times summary feed. September 25 remains the scheduled closing date, so the first-day reading cannot be treated as a final subscription verdict or a forecast of listing performance.

Source check: CapKet retrieved the linked exchange records at approximately 00:57 IST on 24 September 2026. Event dates and source update times are distinguished from this publication date. Later corrections may change the official record.

Disclosure: AI-assisted, independently written reporting from attributed public records; no independent human review is claimed. This is general information, not an investment recommendation. No listing return, dividend receipt or buyback acceptance is guaranteed.